2'-deoxyadenosine triphosphate has been researched along with Severe Combined Immunodeficiency in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackburn, MR; Joachims, ML; Laurent, AB; Marble, PA; Paliotta, M; Pastuszko, P; Thompson, LF | 1 |
| Hirschhorn, R; Huie, ML; Israni, A; Ownby, DR; Yang, DR | 1 |
| Aldrich, M; Blackburn, MR; Chen, W; Datta, SK; Hershfield, MS; Kellems, RE; Kelly, S; Volmer, JB; Zhong, H | 1 |
| Apasov, SG; Blackburn, MR; Kellems, RE; Sitkovsky, MV; Smith, PT | 1 |
| Bain, MD; Bax, BE; Chalmers, RA; Fairbanks, LD; Simmonds, HA; Webster, AD | 1 |
| Duley, JA; Fairbanks, LD; Flood, T; Gaspar, HB; Simmonds, HA; Steward, CA | 1 |
| Borkowsky, W; Eng, F; Hirschhorn, R; Nicknam, MN; Yang, DR | 1 |
7 other study(ies) available for 2'-deoxyadenosine triphosphate and Severe Combined Immunodeficiency
| Article | Year |
|---|---|
Restoration of adenosine deaminase-deficient human thymocyte development in vitro by inhibition of deoxynucleoside kinases.
Topics: Adenosine Deaminase; Animals; Apoptosis; Cell Culture Techniques; Cell Differentiation; Coculture Techniques; Deoxyadenine Nucleotides; Disease Models, Animal; Enzyme Inhibitors; Fetus; Humans; Mice; Phosphotransferases (Alcohol Group Acceptor); Severe Combined Immunodeficiency; Thymus Gland | 2008 |
Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery.
Topics: Adenosine Deaminase; Alleles; Arginine; B-Lymphocytes; Base Sequence; Cell Line; Child, Preschool; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 20; Deoxyadenine Nucleotides; DNA Mutational Analysis; Electrophoresis, Polyacrylamide Gel; Glutamine; Humans; Male; Molecular Sequence Data; Mosaicism; Point Mutation; Remission, Spontaneous; Repetitive Sequences, Nucleic Acid; RNA Splicing; RNA, Messenger; Severe Combined Immunodeficiency; Y Chromosome | 1994 |
The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities.
Topics: Adenosine; Adenosine Deaminase; Adenosylhomocysteinase; Animals; Deoxyadenine Nucleotides; Deoxyadenosines; Disease Models, Animal; Genotype; Histocytochemistry; Hydrolases; Killer Cells, Natural; Lung; Lymphocyte Count; Lymphocytes; Lymphopenia; Mice; Mice, Transgenic; Phenotype; S-Adenosylhomocysteine; Severe Combined Immunodeficiency; Spleen; Thymus Gland | 2000 |
Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.
Topics: Adenosine; Adenosine Deaminase; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Apoptosis; B-Lymphocytes; Calcium Signaling; Cell Differentiation; Cells, Cultured; Deoxyadenine Nucleotides; Deoxyadenosines; Gene Expression Regulation; Lectins, C-Type; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Knockout; Mice, SCID; Organ Specificity; Phosphorylation; Protein Processing, Post-Translational; Receptor-CD3 Complex, Antigen, T-Cell; Receptors, Interleukin-2; Severe Combined Immunodeficiency; Signal Transduction; Specific Pathogen-Free Organisms; Spleen; T-Lymphocytes; Thymus Gland | 2001 |
Carrier erythrocyte entrapped adenosine deaminase therapy in adenosine deaminase deficiency.
Topics: Adenosine Deaminase; Adenosylhomocysteinase; Adult; Deoxyadenine Nucleotides; Erythrocytes; Female; Humans; Hydrolases; Severe Combined Immunodeficiency; Treatment Outcome | 2000 |
ADA activity and DATP levels in erythrocytes after bone marrow transplantation.
Topics: Adenosine Deaminase; Bone Marrow Transplantation; Deoxyadenine Nucleotides; Erythrocytes; Humans; Severe Combined Immunodeficiency; Treatment Outcome | 2000 |
Novel deletion and a new missense mutation (Glu 217 Lys) at the catalytic site in two adenosine deaminase alleles of a patient with neonatal onset adenosine deaminase- severe combined immunodeficiency.
Topics: Adenosine Deaminase; Alleles; Ampicillin; Base Sequence; Chromosomes, Human, Pair 2; Concanavalin A; Deoxyadenine Nucleotides; Deoxyadenosines; DNA Probes; Drug Therapy, Combination; Gene Library; Gentamicins; Humans; Infant; Ketoconazole; Lymphocyte Activation; Male; Molecular Sequence Data; Oxacillin; Phytohemagglutinins; Point Mutation; Pokeweed Mitogens; Promoter Regions, Genetic; Restriction Mapping; Sequence Homology, Nucleic Acid; Severe Combined Immunodeficiency; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |